1 Study Coverage

• 1.1 Next Generation Cancer Diagnostic Devices Product Introduction
• 1.2 Key Market Segments in This Study
• 1.3 Key Manufacturers Covered: Ranking of Global Top Next Generation Cancer Diagnostic Devices Manufacturers by Revenue in 2019
• 1.4 Market by Type
  • 1.4.1 Global Next Generation Cancer Diagnostic Devices Market Size Growth Rate by Type
  • 1.4.2 Next Generation Sequencing
  • 1.4.3 qPCR & Multiplexing
  • 1.4.4 Lab-on- a- chip (LOAC)
  • 1.4.5 Protein Microarrays
  • 1.4.6 DNA Microarrays
  • 1.4.7 Reverse Transcriptase-PCR (RT-PCR)
• 1.5 Market by Application
  • 1.5.1 Global Next Generation Cancer Diagnostic Devices Market Size Growth Rate by Application
  • 1.5.2 Biomarker Development
  • 1.5.3 CTC Analysis
  • 1.5.4 Proteomic Analysis
  • 1.5.5 Epigenetic Analysis
  • 1.5.6 Genetic Analysis
• 1.6 Coronavirus Disease 2019 (Covid-19): Next Generation Cancer Diagnostic Devices Industry Impact
  • 1.6.1 How the Covid-19 is Affecting the Next Generation Cancer Diagnostic Devices Industry
    • 1.6.1.1 Next Generation Cancer Diagnostic Devices Business Impact Assessment - Covid-19
    • 1.6.1.2 Supply Chain Challenges
    • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  • 1.6.2 Market Trends and Next Generation Cancer Diagnostic Devices Potential Opportunities in the COVID-19 Landscape
  • 1.6.3 Measures / Proposal against Covid-19
    • 1.6.3.1 Government Measures to Combat Covid-19 Impact
    • 1.6.3.2 Proposal for Next Generation Cancer Diagnostic Devices Players to Combat Covid-19 Impact
• 1.7 Study Objectives
• 1.8 Years Considered

2 Executive Summary

• 2.1 Global Next Generation Cancer Diagnostic Devices Market Size Estimates and Forecasts
  • 2.1.1 Global Next Generation Cancer Diagnostic Devices Revenue Estimates and Forecasts 2015-2026
  • 2.1.2 Global Next Generation Cancer Diagnostic Devices Production Capacity Estimates and Forecasts 2015-2026
  • 2.1.3 Global Next Generation Cancer Diagnostic Devices Production Estimates and Forecasts 2015-2026
• 2.2 Global Next Generation Cancer Diagnostic Devices Market Size by Producing Regions: 2015 VS 2020 VS 2026
• 2.3 Analysis of Competitive Landscape
  • 2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 2.3.2 Global Next Generation Cancer Diagnostic Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.3.3 Global Next Generation Cancer Diagnostic Devices Manufacturers Geographical Distribution
• 2.4 Key Trends for Next Generation Cancer Diagnostic Devices Markets & Products
• 2.5 Primary Interviews with Key Next Generation Cancer Diagnostic Devices Players (Opinion Leaders)

3 Market Size by Manufacturers

• 3.1 Global Top Next Generation Cancer Diagnostic Devices Manufacturers by Production Capacity
  • 3.1.1 Global Top Next Generation Cancer Diagnostic Devices Manufacturers by Production Capacity (2015-2020)
  • 3.1.2 Global Top Next Generation Cancer Diagnostic Devices Manufacturers by Production (2015-2020)
  • 3.1.3 Global Top Next Generation Cancer Diagnostic Devices Manufacturers Market Share by Production
• 3.2 Global Top Next Generation Cancer Diagnostic Devices Manufacturers by Revenue
  • 3.2.1 Global Top Next Generation Cancer Diagnostic Devices Manufacturers by Revenue (2015-2020)
  • 3.2.2 Global Top Next Generation Cancer Diagnostic Devices Manufacturers Market Share by Revenue (2015-2020)
  • 3.2.3 Global Top 10 and Top 5 Companies by Next Generation Cancer Diagnostic Devices Revenue in 2019
• 3.3 Global Next Generation Cancer Diagnostic Devices Price by Manufacturers
• 3.4 Mergers & Acquisitions, Expansion Plans

4 Next Generation Cancer Diagnostic Devices Production by Regions

• 4.1 Global Next Generation Cancer Diagnostic Devices Historic Market Facts & Figures by Regions
  • 4.1.1 Global Top Next Generation Cancer Diagnostic Devices Regions by Production (2015-2020)
  • 4.1.2 Global Top Next Generation Cancer Diagnostic Devices Regions by Revenue (2015-2020)
• 4.2 North America
  • 4.2.1 North America Next Generation Cancer Diagnostic Devices Production (2015-2020)
  • 4.2.2 North America Next Generation Cancer Diagnostic Devices Revenue (2015-2020)
  • 4.2.3 Key Players in North America
  • 4.2.4 North America Next Generation Cancer Diagnostic Devices Import & Export (2015-2020)
• 4.3 Europe
  • 4.3.1 Europe Next Generation Cancer Diagnostic Devices Production (2015-2020)
  • 4.3.2 Europe Next Generation Cancer Diagnostic Devices Revenue (2015-2020)
  • 4.3.3 Key Players in Europe
  • 4.3.4 Europe Next Generation Cancer Diagnostic Devices Import & Export (2015-2020)
• 4.4 China
  • 4.4.1 China Next Generation Cancer Diagnostic Devices Production (2015-2020)
  • 4.4.2 China Next Generation Cancer Diagnostic Devices Revenue (2015-2020)
  • 4.4.3 Key Players in China
  • 4.4.4 China Next Generation Cancer Diagnostic Devices Import & Export (2015-2020)
• 4.5 Japan
  • 4.5.1 Japan Next Generation Cancer Diagnostic Devices Production (2015-2020)
  • 4.5.2 Japan Next Generation Cancer Diagnostic Devices Revenue (2015-2020)
  • 4.5.3 Key Players in Japan
  • 4.5.4 Japan Next Generation Cancer Diagnostic Devices Import & Export (2015-2020)

5 Next Generation Cancer Diagnostic Devices Consumption by Region

• 5.1 Global Top Next Generation Cancer Diagnostic Devices Regions by Consumption
  • 5.1.1 Global Top Next Generation Cancer Diagnostic Devices Regions by Consumption (2015-2020)
  • 5.1.2 Global Top Next Generation Cancer Diagnostic Devices Regions Market Share by Consumption (2015-2020)
• 5.2 North America
  • 5.2.1 North America Next Generation Cancer Diagnostic Devices Consumption by Application
  • 5.2.2 North America Next Generation Cancer Diagnostic Devices Consumption by Countries
  • 5.2.3 U.S.
  • 5.2.4 Canada
• 5.3 Europe
  • 5.3.1 Europe Next Generation Cancer Diagnostic Devices Consumption by Application
  • 5.3.2 Europe Next Generation Cancer Diagnostic Devices Consumption by Countries
  • 5.3.3 Germany
  • 5.3.4 France
  • 5.3.5 U.K.
  • 5.3.6 Italy
  • 5.3.7 Russia
• 5.4 Asia Pacific
  • 5.4.1 Asia Pacific Next Generation Cancer Diagnostic Devices Consumption by Application
  • 5.4.2 Asia Pacific Next Generation Cancer Diagnostic Devices Consumption by Regions
  • 5.4.3 China
  • 5.4.4 Japan
  • 5.4.5 South Korea
  • 5.4.6 India
  • 5.4.7 Australia
  • 5.4.8 Taiwan
  • 5.4.9 Indonesia
  • 5.4.10 Thailand
  • 5.4.11 Malaysia
  • 5.4.12 Philippines
  • 5.4.13 Vietnam
• 5.5 Central & South America
  • 5.5.1 Central & South America Next Generation Cancer Diagnostic Devices Consumption by Application
  • 5.5.2 Central & South America Next Generation Cancer Diagnostic Devices Consumption by Country
  • 5.5.3 Mexico
  • 5.5.3 Brazil
  • 5.5.3 Argentina
• 5.6 Middle East and Africa
  • 5.6.1 Middle East and Africa Next Generation Cancer Diagnostic Devices Consumption by Application
  • 5.6.2 Middle East and Africa Next Generation Cancer Diagnostic Devices Consumption by Countries
  • 5.6.3 Turkey
  • 5.6.4 Saudi Arabia
  • 5.6.5 U.A.E

6 Market Size by Type (2015-2026)

• 6.1 Global Next Generation Cancer Diagnostic Devices Market Size by Type (2015-2020)
  • 6.1.1 Global Next Generation Cancer Diagnostic Devices Production by Type (2015-2020)
  • 6.1.2 Global Next Generation Cancer Diagnostic Devices Revenue by Type (2015-2020)
  • 6.1.3 Next Generation Cancer Diagnostic Devices Price by Type (2015-2020)
• 6.2 Global Next Generation Cancer Diagnostic Devices Market Forecast by Type (2021-2026)
  • 6.2.1 Global Next Generation Cancer Diagnostic Devices Production Forecast by Type (2021-2026)
  • 6.2.2 Global Next Generation Cancer Diagnostic Devices Revenue Forecast by Type (2021-2026)
  • 6.2.3 Global Next Generation Cancer Diagnostic Devices Price Forecast by Type (2021-2026)
• 6.3 Global Next Generation Cancer Diagnostic Devices Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

7 Market Size by Application (2015-2026)

• 7.2.1 Global Next Generation Cancer Diagnostic Devices Consumption Historic Breakdown by Application (2015-2020)
• 7.2.2 Global Next Generation Cancer Diagnostic Devices Consumption Forecast by Application (2021-2026)

8 Corporate Profiles

• 8.1 Roche Holding Ltd.（Switzerland)
  • 8.1.1 Roche Holding Ltd.（Switzerland) Corporation Information
  • 8.1.2 Roche Holding Ltd.（Switzerland) Overview and Its Total Revenue
  • 8.1.3 Roche Holding Ltd.（Switzerland) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
  • 8.1.4 Roche Holding Ltd.（Switzerland) Product Description
  • 8.1.5 Roche Holding Ltd.（Switzerland) Recent Development
• 8.2 Abbott Laboratories(US)
  • 8.2.1 Abbott Laboratories(US) Corporation Information
  • 8.2.2 Abbott Laboratories(US) Overview and Its Total Revenue
  • 8.2.3 Abbott Laboratories(US) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
  • 8.2.4 Abbott Laboratories(US) Product Description
  • 8.2.5 Abbott Laboratories(US) Recent Development
• 8.3 Siemens Healthcare(Germany)
  • 8.3.1 Siemens Healthcare(Germany) Corporation Information
  • 8.3.2 Siemens Healthcare(Germany) Overview and Its Total Revenue
  • 8.3.3 Siemens Healthcare(Germany) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
  • 8.3.4 Siemens Healthcare(Germany) Product Description
  • 8.3.5 Siemens Healthcare(Germany) Recent Development
• 8.4 Agilent Technologies Inc(Germany)
  • 8.4.1 Agilent Technologies Inc(Germany) Corporation Information
  • 8.4.2 Agilent Technologies Inc(Germany) Overview and Its Total Revenue
  • 8.4.3 Agilent Technologies Inc(Germany) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
  • 8.4.4 Agilent Technologies Inc(Germany) Product Description
  • 8.4.5 Agilent Technologies Inc(Germany) Recent Development
• 8.5 Illumina Inc.(US)
  • 8.5.1 Illumina Inc.(US) Corporation Information
  • 8.5.2 Illumina Inc.(US) Overview and Its Total Revenue
  • 8.5.3 Illumina Inc.(US) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
  • 8.5.4 Illumina Inc.(US) Product Description
  • 8.5.5 Illumina Inc.(US) Recent Development
• 8.6 Becton Dickinson and Co.(US)
  • 8.6.1 Becton Dickinson and Co.(US) Corporation Information
  • 8.6.2 Becton Dickinson and Co.(US) Overview and Its Total Revenue
  • 8.6.3 Becton Dickinson and Co.(US) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
  • 8.6.4 Becton Dickinson and Co.(US) Product Description
  • 8.6.5 Becton Dickinson and Co.(US) Recent Development
• 8.7 QIAGEN N.V.(Germany)
  • 8.7.1 QIAGEN N.V.(Germany) Corporation Information
  • 8.7.2 QIAGEN N.V.(Germany) Overview and Its Total Revenue
  • 8.7.3 QIAGEN N.V.(Germany) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
  • 8.7.4 QIAGEN N.V.(Germany) Product Description
  • 8.7.5 QIAGEN N.V.(Germany) Recent Development
• 8.8 Affymetrix Inc.(US)
  • 8.8.1 Affymetrix Inc.(US) Corporation Information
  • 8.8.2 Affymetrix Inc.(US) Overview and Its Total Revenue
  • 8.8.3 Affymetrix Inc.(US) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
  • 8.8.4 Affymetrix Inc.(US) Product Description
  • 8.8.5 Affymetrix Inc.(US) Recent Development
• 8.9 Johnson & Johnson(US)
  • 8.9.1 Johnson & Johnson(US) Corporation Information
  • 8.9.2 Johnson & Johnson(US) Overview and Its Total Revenue
  • 8.9.3 Johnson & Johnson(US) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
  • 8.9.4 Johnson & Johnson(US) Product Description
  • 8.9.5 Johnson & Johnson(US) Recent Development
• 8.10 Thermo Fisher Scientific Inc.(US)
  • 8.10.1 Thermo Fisher Scientific Inc.(US) Corporation Information
  • 8.10.2 Thermo Fisher Scientific Inc.(US) Overview and Its Total Revenue
  • 8.10.3 Thermo Fisher Scientific Inc.(US) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
  • 8.10.4 Thermo Fisher Scientific Inc.(US) Product Description
  • 8.10.5 Thermo Fisher Scientific Inc.(US) Recent Development
• 8.11 GE Healthcare(England)
  • 8.11.1 GE Healthcare(England) Corporation Information
  • 8.11.2 GE Healthcare(England) Overview and Its Total Revenue
  • 8.11.3 GE Healthcare(England) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
  • 8.11.4 GE Healthcare(England) Product Description
  • 8.11.5 GE Healthcare(England) Recent Development
• 8.12 Life Technologies Corp.(US)
  • 8.12.1 Life Technologies Corp.(US) Corporation Information
  • 8.12.2 Life Technologies Corp.(US) Overview and Its Total Revenue
  • 8.12.3 Life Technologies Corp.(US) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
  • 8.12.4 Life Technologies Corp.(US) Product Description
  • 8.12.5 Life Technologies Corp.(US) Recent Development
• 8.13 Luminex Corp.(US)
  • 8.13.1 Luminex Corp.(US) Corporation Information
  • 8.13.2 Luminex Corp.(US) Overview and Its Total Revenue
  • 8.13.3 Luminex Corp.(US) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
  • 8.13.4 Luminex Corp.(US) Product Description
  • 8.13.5 Luminex Corp.(US) Recent Development
• 8.14 Cepheid Inc.(US)
  • 8.14.1 Cepheid Inc.(US) Corporation Information
  • 8.14.2 Cepheid Inc.(US) Overview and Its Total Revenue
  • 8.14.3 Cepheid Inc.(US) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
  • 8.14.4 Cepheid Inc.(US) Product Description
  • 8.14.5 Cepheid Inc.(US) Recent Development
• 8.15 Allegro Diagnostics Corp.(Brazil)
  • 8.15.1 Allegro Diagnostics Corp.(Brazil) Corporation Information
  • 8.15.2 Allegro Diagnostics Corp.(Brazil) Overview and Its Total Revenue
  • 8.15.3 Allegro Diagnostics Corp.(Brazil) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
  • 8.15.4 Allegro Diagnostics Corp.(Brazil) Product Description
  • 8.15.5 Allegro Diagnostics Corp.(Brazil) Recent Development

9 Production Forecasts by Regions

• 9.1 Global Top Next Generation Cancer Diagnostic Devices Regions Forecast by Revenue (2021-2026)
• 9.2 Global Top Next Generation Cancer Diagnostic Devices Regions Forecast by Production (2021-2026)
• 9.3 Key Next Generation Cancer Diagnostic Devices Production Regions Forecast
  • 9.3.1 North America
  • 9.3.2 Europe
  • 9.3.3 China
  • 9.3.4 Japan

10 Next Generation Cancer Diagnostic Devices Consumption Forecast by Region

• 10.1 Global Next Generation Cancer Diagnostic Devices Consumption Forecast by Region (2021-2026)
• 10.2 North America Next Generation Cancer Diagnostic Devices Consumption Forecast by Region (2021-2026)
• 10.3 Europe Next Generation Cancer Diagnostic Devices Consumption Forecast by Region (2021-2026)
• 10.4 Asia Pacific Next Generation Cancer Diagnostic Devices Consumption Forecast by Region (2021-2026)
• 10.5 Latin America Next Generation Cancer Diagnostic Devices Consumption Forecast by Region (2021-2026)
• 10.6 Middle East and Africa Next Generation Cancer Diagnostic Devices Consumption Forecast by Region (2021-2026)

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Next Generation Cancer Diagnostic Devices Sales Channels
  • 11.2.2 Next Generation Cancer Diagnostic Devices Distributors
• 11.3 Next Generation Cancer Diagnostic Devices Customers

12 Market Opportunities & Challenges, Risks and Influences Factors Analysis

• 12.1 Market Opportunities and Drivers
• 12.2 Market Challenges
• 12.3 Market Risks/Restraints
• 12.4 Porter's Five Forces Analysis

13 Key Finding in The Global Next Generation Cancer Diagnostic Devices Study

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
  • 14.1.2 Data Source
• 14.2 Author Details

Next Generation Cancer Diagnostic Devices market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Next Generation Cancer Diagnostic Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Next Generation Cancer Diagnostic Devices market is segmented into
Next Generation Sequencing
qPCR & Multiplexing
Lab-on- a- chip (LOAC)
Protein Microarrays
DNA Microarrays
Reverse Transcriptase-PCR (RT-PCR)

Segment by Application, the Next Generation Cancer Diagnostic Devices market is segmented into
Biomarker Development
CTC Analysis
Proteomic Analysis
Epigenetic Analysis
Genetic Analysis

Regional and Country-level Analysis
The Next Generation Cancer Diagnostic Devices market is analysed and market size information is provided by regions (countries).
The key regions covered in the Next Generation Cancer Diagnostic Devices market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and Next Generation Cancer Diagnostic Devices Market Share Analysis

Next Generation Cancer Diagnostic Devices market competitive landscape provides details and data information by manufacturers. The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of Next Generation Cancer Diagnostic Devices by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on production, revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue, and the production capacity, price, revenue generated in Next Generation Cancer Diagnostic Devices business, the date to enter into the Next Generation Cancer Diagnostic Devices market, Next Generation Cancer Diagnostic Devices product introduction, recent developments, etc.
The major vendors covered:
Roche Holding Ltd.（Switzerland)
Abbott Laboratories(US)
Siemens Healthcare(Germany)
Agilent Technologies Inc(Germany)
Illumina Inc.(US)
Becton Dickinson and Co.(US)
QIAGEN N.V.(Germany)
Affymetrix Inc.(US)
Johnson & Johnson(US)
Thermo Fisher Scientific Inc.(US)
GE Healthcare(England)
Life Technologies Corp.(US)
Luminex Corp.(US)
Cepheid Inc.(US)